CAbotégravir LENacapavir DUal Long Acting

Stopped No response regarding coverage of treatments by social security and the DGOS

Conditions

• HIV1 Infection
• Multi-treated Patients Who Have Received Multiple Lines of Antiretroviral Treatment
• CABOTEGRAVIR
• LENACAPAVIR
• Stable Oral Antiretroviral Treatment for at Least 6 Months

Interventions

• DRUG: his is a prospective, single-arm, multicentre, non-randomised phase II, pilot study designed to achieve or maintain virological success in participants who meet the prescribing criteria for lenacapavi

Sponsor

Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba

Collaborators

• [object Object]